Skip to content

Axogen AXGN International — Revenue

Similar metrics at other companies

Worthington Enterprises logo
WORInternational — Revenue
$65.58M-18.6%
Crocs logo
CROXInternational — Revenue
$421.49M+7.2%
Steven Madden logo
SHOOInternational — Revenue
$227.96M+122%
Grindr logo
GRNDInternational — Revenue
$55.91M+44.6%
MGN
MGNIInternational — Revenue
$41.08M+5.4%
Braze, Inc. logo
BRZEInternational — Revenue
$95.49M+28.8%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's international — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's international — revenue?
Axogen (AXGN) reported international — revenue of $1.33M in Q1 2026.
How has Axogen's international — revenue changed year-over-year?
Axogen's international — revenue increased by 84.9% year-over-year, from $717K to $1.33M.
What does international — revenue mean?
This metric represents the total gross sales generated from products and services sold to customers located outside of the company's primary domestic market. It serves as a key indicator of the company's global commercial footprint and its ability to successfully navigate regulatory and market adoption challenges in international healthcare systems. Monitoring this revenue stream helps investors assess the scalability of the company's specialized medical technology portfolio across diverse geographic regions.